Nothing Special   »   [go: up one dir, main page]

Hwang et al., 1983 - Google Patents

Immunogenicity of HBV vaccine in healthy Chinese children

Hwang et al., 1983

Document ID
17473177127110248140
Author
Hwang L
Beasley R
Stevens C
Szmuness W
Publication year
Publication venue
Vaccine

External Links

Snippet

The immunogenic response of healthy Chinese children to three different doses of hepatitis B virus (HBV) vaccine was compared. One hundred susceptible children received two doses of 10, 20 or 40 μg a month apart. A month following the first dose 33% of all the children had …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse Transcribing DNA Viruses
    • C12N2730/00011—Reverse Transcribing DNA Viruses
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011—Flaviviridae

Similar Documents

Publication Publication Date Title
Zajac et al. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA
Lok et al. Long-term follow-up in a randomised controlled trial of recombinant α2-interferon in Chinese patients with chronic hepatitis B infection
Beasley et al. Incidence of hepatitis B virus infections in preschool children in Taiwan
Stevens et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
Andre Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
Scolnick et al. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA
Söderström et al. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission
Beasley et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
Lee et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease
Ghendon WHO strategy for the global elimination of new cases of hepatitis B
Lee et al. Hepatitis B vaccination in patients with chronic hepatitis C
Dandolos et al. Safety and immunogenicity of a recombinant hepatitis B vaccine
Yvonnet et al. Simultaneous administration of hepatitis B and yellow fever vaccines
Chang et al. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus
Goh et al. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study
Hwang et al. Immunogenicity of HBV vaccine in healthy Chinese children
Grose et al. Guillain-Barré syndrome following administration of live measles vaccine
Goh et al. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults
Bogomolski‐Yahalom et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk
Wahl et al. Immune responses to hepatitis B vaccine in the mentally retarded
Chan Changing scene in hepatitis B serology interpretation
Kuramoto et al. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination
Gust et al. The prevalence of HBeAg and anti‐HBe in an institution for the mentally retarded
EP0998301B1 (en) Nucleic acid based immunotherapy of chronic hepatitis b infection
Zahradnik et al. Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology